The three sites most often used for distal radial artery access are the (1) anatomic snuffbox above the scaphoid (left), (2) adjacent to the snuffbox at the trapezium bone (center), and (3) the first intermetacarpal space (right). The author’s preference is either of the first two options, although good outcomes have been reported with use of the intermetacarpal space.
Feature | Radial Access | Enrique Flores, M.D., RPVI
Incorporating Distal Radial Artery Access Into Clinical Practice

Interest in distal radial artery access (DRA) is growing rapidly. Among the benefits of DRA are the low risk of entry ...

Home November 21, 2019
Home
EKO digital stethoscopes
News | AHA
Eko and Mayo Clinic Prove Heart Failure is Detectable at Point of Care Using ECG-Enabled Stethoscope

November 21, 2019 — At the American Heart Association Scientific Sessions 2019, Eko, a digital health company applying ...

Home November 21, 2019
Home
cardiac arrest cath lab
News | AHA
Weekend Sudden Cardiac Arrests are More Deadly

November 21, 2019 — People who experience cardiac arrests over the weekend are less likely to survive long enough to be ...

Home November 21, 2019
Home
The Cordella Pulmonary Artery Pressure Sensor System for Heart failure. #AHA19 #AHA
News | Heart Failure
Positive Results for SIRONA First-in-Human Trial of the Cordella PA Pressure Sensor System

November 21, 2019 — Endotronix, a digital health and medical technology company dedicated to advancing the treatment of ...

Home November 21, 2019
Home
John J. V. McMurray presenting the DAPA-HF Trial at AHA 2019. It was part of the late-breaking presentations in the "Outside the Box: New Approaches to CVD Risk Reduction" session.
Blog | Heart Failure
Key Heart Failure Takeaways at AHA 2019

It’s an exciting time in the heart failure (HF) world right now with the emergence of new therapies, including ...

Home November 21, 2019
Home
Heart failure VICTORIA TrIal a success. Dave Fornell
News | Heart Failure
Investigational Drug Vericiguat Reduced the Risk of Heart Failure Hospitalization in VICTORIA Trial

November 21, 2019 — Merck announced the results from the Phase 3 VICTORIA Study evaluating the efficacy and safety of ...

Home November 21, 2019
Home
heart disease
News | AHA
Heart Disease and Cancer Risk May be Linked

November 20, 2019 — Heart attack survivors may have an increased risk of developing cancer compared to people without ...

Home November 20, 2019
Home
Assorted pastries
News | AHA
Too Much Ultra Processed Food Linked to Lower Heart Health

November 20, 2019 — Ultra-processed foods, which account for more than half of an average American’s daily calories, are ...

Home November 20, 2019
Home
marijuana leaf
News | AHA
Cannabis May be Linked to Strokes and Heart Rhythm Disturbances in Young People

November 20, 2019 — Frequent cannabis (marijuana) use among young people was linked to an increased risk of stroke, and ...

Home November 20, 2019
Home
In the ISCHEMIA study, patients were randomized into one of two groups: a conservative strategy or an invasive strategy. Illustration by NYU Langone staff
Feature | AHA
ISCHEMIA Trial Results Find Interventions for Stable Heart Disease No better Than Drug Therapy

November 19, 2019 — After 12 years of collecting data, the results of the landmark ISCHEMIA (International Study of ...

Home November 19, 2019
Home
Since Maquet/Datascope first recalled all of its intra-aortic balloon pumps (IABP) due to reports of the batteries failing in November 2018, a year later the U.S. Food and Drug Administration said its has received more than 60 additional medical device reports related to this issue. These included two patient deaths and one serious patient injury.
News
Over 60 New Safety Reports Filed With FDA for Maquet IABPs Turning Off During Use

November 19, 2019 — Since Maquet/Datascope first recalled all of its intra-aortic balloon pumps (IABP) due to reports of ...

Home November 19, 2019
Home
The American Heart Association, AHA, 2019 meeting late breaking trials and key studies on cardiovascular science.
Feature | AHA | Dave Fornell, Editor
American Heart Association 2019 Late-breaking Trials

Here is a list of the key late-breaking clinical study presentations at the 2019 American Heart Association (AHA) annual meeting, Nov. 16-18, 2019, in Philadelphia.

Home November 19, 2019
Home
Results from the MARVEL 2 (Micra Atrial Tracking Using A Ventricular accELerometer) study shows that an investigational set of algorithms in the Medtronic Micra Transcatheter Pacing System (TPS) significantly improves synchrony and cardiac function in patients with atrioventricular (AV) block. This is an impaired electrical conduction between the chambers of the heart.
News | Pacemakers
New Algorithms in Medtronic Micra Pacemaker May Improve Synchrony and Cardiac Function in AV Block

(February 2020 update — the results of this trial led to the FDA clearnace of the Micra AV device in January 2020 - FDA ...

Home November 15, 2019
Home
The ClotTriever system (Inari Medical), a mechanical thrombectomy system FDA 510(k) cleared for the nonsurgical removal of soft thrombi and emboli from peripheral blood vessels. #VIVA19 #VIVA2019
News | Deep Vein Thrombosis (DVT)
DVT ClotTriever (CLOUT) Registry Shows Significant Improvement

November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)
The ULYSSE Registry Shows Benefit of Ultrasoundplasty Before Below-the-knee Interventions

November 7, 2019 — Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...

Home November 14, 2019
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now